Ownership history in B Group, Inc. · 5 quarters on record
This page tracks every 13F SEC filing in which B Group, Inc. reported a position in APOGEE THERAPEUTICS INC (APGE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 20,000 | -15,000 | -42.9% | 1.11% | $1.5M | $75.48 |
| 2025 Q3 | UNCHANGED | 35,000 | — | 0% | 1.02% | $1.4M | $39.73 |
| 2025 Q2 | ADDED | 35,000 | +5,000 | +16.7% | 1.17% | $1.5M | $43.43 |
| 2025 Q1 | ADDED | 30,000 | +15,000 | +100.0% | 0.96% | $1.1M | $37.36 |
As of 2025 Q4 — sorted by position size